Facial Injectables Market, by Product Type (Dermal Fillers, and Anti-wrinkle Injection), by Application (Wrinkle Reduction, Facelift, Lip Enhancement, and Others) by End User (Hospitals, Dermatology Centers, Beauty Clinics, and Others), and by Region - Global Trends, and Forecast till 2025

Facial Injectables Market – Restoring the Radiance of Youth

Facial injectable aid in rejuvenating facial skin by reducing or eliminating wrinkles, raising scar depressions, and enhancing lips. Facial injectable are products that include collagen fillers, hyaluronic acid fillers, and synthetic fillers such as calcium hydroxyl apatite. The use of injectable products such as hyaluronic acid increases skin hydration, improves skin, and protects from UV damage and has relatively low side effects. These factors are anticipated to drive the market growth over the forecast years. Moreover, increasing demand for products that enhance personal beauty, rising consciousness about aesthetics, introduction of cost-effective facial injectable, and growing inclination towards minimally invasive procedures is anticipated to fuel the market growth.

The global facial injectables market was valued at US$ 6,253.7 million in 2016 and is expected to exhibit a robust CAGR of 11.9% over the forecast period (2017–2025).

Figure 1. Global Facial Injectables Market Value (US$ Mn), by Region, 2016

facial injectable market

Source: Coherent Market Insights (2018)

Increasing preference for non-invasive procedures to augment market growth

Increasing demand for non-surgical procedures for facial rejuvenation and correction is expected to be a factor augmenting growth of the facial injectables market. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), 2017, surgical and non-surgical cosmetic procedures exhibited an overall increase of 9% from 2016-2017. ISAPS also stated that nonsurgical procedures including injectable accounted for around 8,548,597 in 2016, globally. According to the British Association of Aesthetic Plastic Surgeons, 2013, anti-ageing facelifts and brow lifts cosmetic operations exhibited a 17% rise as compared to the year 2012 globally, thus indicating rise in adoption of facial injectable.

North America is dominant in the global facial injectables market, owing to increasing awareness about advanced beauty treatments and growing emphasis about physical appearance. According to research by Galderma S.A., 2017, around 2 million women in the U.S. regularly undergo aesthetic injectable procedures, while around 17 million are considering aesthetic injectable treatment, thereby, leading to increasing demand for facial injectable. Also, according to the American Society of Aesthetic Plastic Surgery, 2016, an increase of 93% in non-surgical procedures was observed in men and women aged 35–55 years from 2011-2016. Moreover, launch of novel products in the region by key players is a major factor accelerating the market growth. For instance, in 2016, Allergan Plc., launched an additional product in Juvederm collection of fillers, Juvederm Volbella XC, for lip augmentation and for correction of perioral rhytids, referred as lipstick lines, in adults over the age of 21. Juvéderm Volbella XC is the only filler proven to last for one year in both the lips and perioral rhytids with optimal treatment.

Supportive government and non-government initiatives to accelerate the market growth  

Various organizations are conducting educational programs, scientific meetings to provide knowledge about the latest research and procedures, in turn increasing awareness among patients and plastic surgeons, thus bolstering the market growth. For instance, the International Society of Aesthetic Plastic Surgery (ISAPS) is a professional organization for board-certified aesthetic plastic surgeons, dedicated to promote excellence in the field of aesthetic plastic surgery globally. The Society offers instructional courses, symposia, and educational programs, while the members of ISAPS have access to the most advanced techniques such as botulinum toxin and dermal fillers. Moreover, the American Academy of Facial Esthetics (AAFE) aims to provide information about non-surgical and non-invasive facial injectable techniques to healthcare professionals worldwide. AAFE is also committed to providing the best possible outcomes in areas of facial esthetics and facial pain treatment.

Key players are adopting collaborations and product launches strategies in order to address the unmet aesthetic needs thereby, providing physicians with new and better options, augmenting growth of facial injectables market. For instance, in 2017, Galderma collaborated with Colorescience to expand its skincare solutions for individuals that can be used in conjunction with conventional facial injectable aesthetic treatments.

Major players operating in the global facial injectables market are Allergan, Plc., Galderma S.A., Integra LifeSciences Corporation, Merz Pharma GmbH & Co. KGaA., Sanofi S.A., SciVision Biotech Inc., Sinclair Pharma Plc., Suneva Medical, Valeant Pharmaceuticals International, Inc., and Anika Therapeutics, Inc.

Facial injectable are called as facial fillers and are used in aesthetic therapeutic procedures to enhance facial looks. Facial injectable are used for smoothening wrinkles and scars on the face by filling the target area. Dermal fillers reduce wrinkles and add volume to the cheeks and lips and are injected directly in the wrinkles, while anti-wrinkle injections relax the muscles that cause creases. Facial injectable are mostly used for treating early signs of aging and increasing the aesthetic beauty. Some of the most commonly used facial injectable are collagens, hyaluronic acids, polymers, and botulinum toxin.

Market Dynamics

Major factors driving growth of the facial injectables market include increasing preference for non-surgical invasive cosmetics surgeries, increasing FDA approval of novel products, and rising demand for facial injectable to enhance aesthetic beauty. For instance, in 2017, Allergan Plc. received FDA approval for Juvederm Vollure for use in the U.S., while the product was previously available in Europe. Moreover, increasing promotional activities, rapidly developing healthcare infrastructure, and rising disposable income are the factors to propel the facial injectables market. For instance, according to the American Society for Aesthetic Plastic Surgery (ASAPS), 2016, the people in the U.S. spend over US$ 15 billion on combined surgical and non-surgical aesthetic procedures, accounting for an 11% increase over the year 2015. However, stringent regulations and side effects associated with injectable such as bruising, discoloration, and rashes are expected to negatively affect the market growth. 

Key features of the study:

  • This report provides in-depth analysis of facial injectables market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global facial injectables market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Allergan, Plc., Galderma S.A., Integra LifeSciences Corporation, Merz Pharma GmbH & Co. KGaA., Sanofi S.A., SciVision Biotech Inc., Sinclair Pharma Plc., Suneva Medical, Valeant Pharmaceuticals International, Inc., and Anika Therapeutics, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global facial injectables market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the facial injectables market

Detailed Segmentation:

  • Global Facial Injectables Market, By Product Type:
    • Dermal Fillers
      • Hyaluronic Acid Fillers
      • Collagen Fillers
      • Synthetic Fillers
    • Anti-wrinkle Injection
      • Botulinum Toxin A
      • Poly-L-lactic Acid (PLLA)
  • Global Facial Injectables Market, By Application:
    • Wrinkle Reduction
    • Facelift
    • Lip Enhancement
    • Others
  • Global Facial Injectables Market, By End User:
    • Hospitals
    • Dermatology Centers
    • Beauty Clinics
    • Others
  • Global Facial Injectables Market, By Geography:
    • North America
      • By Product Type:
        • Dermal Fillers
          • Hyaluronic Acid Fillers
          • Collagen Fillers
          • Synthetic Fillers
        • Anti-wrinkle Injection
          • Botulinum Toxin A
          • Poly-L-lactic Acid (PLLA)
      • By Application:
        • Wrinkle Reduction
        • Facelift
        • Lip Enhancement
        • Others
      • By End User:
        • Hospitals
        • Dermatology Centers
        • Beauty Clinics
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Dermal Fillers
          • Hyaluronic Acid Fillers
          • Collagen Fillers
          • Synthetic Fillers
        • Anti-wrinkle Injection
          • Botulinum Toxin A
          • Poly-L-lactic Acid (PLLA)
      • By Application:
        • Wrinkle Reduction
        • Facelift
        • Lip Enhancement
        • Others
      • By End User:
        • Hospitals
        • Dermatology Centers
        • Beauty Clinics
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Dermal Fillers
          • Hyaluronic Acid Fillers
          • Collagen Fillers
          • Synthetic Fillers
        • Anti-wrinkle Injection
          • Botulinum Toxin A
          • Poly-L-lactic Acid (PLLA)
      • By Application:
        • Wrinkle Reduction
        • Facelift
        • Lip Enhancement
        • Others
      • By End User:
        • Hospitals
        • Dermatology Centers
        • Beauty Clinics
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Dermal Fillers
          • Hyaluronic Acid Fillers
          • Collagen Fillers
          • Synthetic Fillers
        • Anti-wrinkle Injection
          • Botulinum Toxin A
          • Poly-L-lactic Acid (PLLA)
      • By Application:
        • Wrinkle Reduction
        • Facelift
        • Lip Enhancement
        • Others
      • By End User:
        • Hospitals
        • Dermatology Centers
        • Beauty Clinics
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Dermal Fillers
          • Hyaluronic Acid Fillers
          • Collagen Fillers
          • Synthetic Fillers
        • Anti-wrinkle Injection
          • Botulinum Toxin A
          • Poly-L-lactic Acid (PLLA)
      • By Application:
        • Wrinkle Reduction
        • Facelift
        • Lip Enhancement
        • Others
      • By End User:
        • Hospitals
        • Dermatology Centers
        • Beauty Clinics
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Dermal Fillers
          • Hyaluronic Acid Fillers
          • Collagen Fillers
          • Synthetic Fillers
        • Anti-wrinkle Injection
          • Botulinum Toxin A
          • Poly-L-lactic Acid (PLLA)
      • By Application:
        • Wrinkle Reduction
        • Facelift
        • Lip Enhancement
        • Others
      • By End User:
        • Hospitals
        • Dermatology Centers
        • Beauty Clinics
        • Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Allergan, Plc. *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Galderma S.A.
    • Integra LifeSciences Corporation
    • Merz Pharma GmbH & Co. KGaA
    • Sanofi S.A.
    • SciVision Biotech Inc.
    • Sinclair Pharma Plc.
    • Suneva Medical
    • Valeant Pharmaceuticals International, Inc.
    • Anika Therapeutics, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • Regulatory Scenario
    • Reimbursement Scenario
    • PEST Analysis
    • Epidemiology
  4. Global Facial Injectables Market, By Product Type, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Dermal Fillers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
      • Segment Trends
        • Hyaluronic Acid Fillers
        • Collagen Fillers
        • Synthetic Fillers
    • Anti-wrinkle Injections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
      • Segment Trends
        • Botulinum Toxin A
        • Poly-L-lactic acid (PLLA)
  5. Global Facial Injectables Market, By Application, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Wrinkle Reduction
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Facelift
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Lip Enhancement
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  6. Global Facial Injectables Market, By End User, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Dermatology Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Beauty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  7. Global Facial Injectables Market, By Region, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2025
    • North America
      • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015–2025, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015–2025, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015–2025, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015–2025, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015–2025, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015–2025, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • Allergan, Plc.*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Galderma S.A.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Integra LifeSciences Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Merz Pharma GmbH & Co. KGaA
        •  Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Sanofi S.A.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • SciVision Biotech Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Sinclair Pharma Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Suneva Medical
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Valeant Pharmaceuticals International, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Anika Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 24 figures on "Facial Injectables Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.